TREM2 and Alzheimer disease: In APP/PS1 mice, both TLR4 and TREM2 are elevated at the protein level [185]; the treatment of these mice with LPS, a ligand for TLR4, resulted in worsened cognitive impairment in these mice, suggesting that superimposition of systemic inflammation due to bacterial infection could speed up the AD progression.